{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:22:02Z","timestamp":1785338522188,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone metastasis (BM) is rare in patients with pancreatic cancer (PC), but often neglected at the initial diagnosis and treatment. Bone metastasis is associated with a worse prognosis. This study was aimed to perform a large data analysis to determine the predictors and prognostic factors of BM in PC patients and to develop two nomograms to quantify the risks of BM and the prognosis of PC patients with BM. In the present study, we reviewed and collected the data of patients who were diagnosed as PC from 2010 to 2015 in the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regression analyses were used together to screen and validate the risk factors for BM in PC patients. The independent prognostic factors for PC patients with BM were identified by Cox regression analysis. Finally, two nomograms were established via calibration curves, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA). This study included 16,474 PC patients from the SEER database, and 226 of them were diagnosed with BM. The risk factors of BM for PC patients covered age, grade, T stage, N stage, tumor size, and primary site. The independent prognostic factors for PC patients with BM included age, race, grade, surgery, and lung metastasis. The AUC of the diagnostic nomogram was 0.728 in the training set and 0.690 in the testing set. In the prognostic nomogram, the AUC values of 6\/12\/18\u00a0month were 0.781\/0.833\/0.849 in the training set and 0.738\/0.781\/0.772 in the testing set. The calibration curve and DCA furtherly indicated the satisfactory clinical consistency of the nomograms. These nomograms could be accurate and personalized tools to predict the incidence of BM in PC patients and the prognosis of PC patients with BM. The nomograms can help clinicians make more personalized and effective treatment choices.<\/jats:p>","DOI":"10.1038\/s41598-022-21899-6","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T14:06:21Z","timestamp":1666879581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis"],"prefix":"10.1038","volume":"12","author":[{"given":"Zongtai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"issue":"4","key":"21899_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000267","volume":"7","author":"S Gillen","year":"2010","unstructured":"Gillen, S., Schuster, T., Meyer ZumB\u00fcschenfelde, C., Friess, H. & Kleeff, J. Preoperative\/neoadjuvant therapy in pancreatic cancer: A systematic review and meta-analysis of response and resection percentages. PLoS Med. 7(4), e1000267 (2010).","journal-title":"PLoS Med."},{"issue":"9974","key":"21899_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0140-6736(14)61396-9","volume":"385","author":"M Quaresma","year":"2015","unstructured":"Quaresma, M., Coleman, M. P. & Rachet, B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971\u20132011: A population-based study. Lancet (London, England). 385(9974), 1206\u20131218 (2015).","journal-title":"Lancet (London, England)."},{"issue":"1","key":"21899_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","volume":"16","author":"O Strobel","year":"2019","unstructured":"Strobel, O., Neoptolemos, J., J\u00e4ger, D. & B\u00fcchler, M. W. Optimizing the outcomes of pancreatic cancer surgery. Nat. Rev. Clin. Oncol. 16(1), 11\u201326 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"21899_CR4","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/S0016-5085(99)70298-2","volume":"117","author":"EP DiMagno","year":"1999","unstructured":"DiMagno, E. P., Reber, H. A. & Tempero, M. A. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 117(6), 1464\u20131484 (1999).","journal-title":"Gastroenterology"},{"issue":"10","key":"21899_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076052","volume":"8","author":"J Luo","year":"2013","unstructured":"Luo, J., Xiao, L., Wu, C., Zheng, Y. & Zhao, N. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004\u20132009. PLoS\u00a0One 8(10), e76052 (2013).","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"21899_CR6","first-page":"2303","volume":"17","author":"Z Guan","year":"2019","unstructured":"Guan, Z., Lan, H., Sun, D., Wang, X. & Jin, K. A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft model. Oncol. Lett. 17(2), 2303\u20132307 (2019).","journal-title":"Oncol. Lett."},{"issue":"1","key":"21899_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000225100","volume":"33","author":"DR Hatfield","year":"1976","unstructured":"Hatfield, D. R., DeLand, F. H. & Maruyama, Y. Skeletal metastases in pancreatic carcinoma: Study by isotopic bone scanning. Oncology 33(1), 44\u201347 (1976).","journal-title":"Oncology"},{"issue":"1","key":"21899_CR8","first-page":"1","volume":"82","author":"MJ Borad","year":"2009","unstructured":"Borad, M. J. et al. Skeletal metastases in pancreatic cancer: A retrospective study and review of the literature. Yale J. Biol. Med. 82(1), 1\u20136 (2009).","journal-title":"Yale J. Biol. Med."},{"issue":"4","key":"21899_CR9","first-page":"298","volume":"7","author":"E Tamm","year":"2001","unstructured":"Tamm, E. & Charnsangavej, C. Pancreatic cancer: Current concepts in imaging for diagnosis and staging. Cancer J. 7(4), 298\u2013311 (2001).","journal-title":"Cancer J."},{"issue":"8","key":"21899_CR10","first-page":"872","volume":"101","author":"H Iguchi","year":"2004","unstructured":"Iguchi, H., Yasuda, M., Matsuo, T., Sumii, T. & Funakoshi, A. Clinical features and management of pancreatic cancer with bone metastases. Nihon Shokakibyo Gakkai Zasshi. 101(8), 872\u2013878 (2004).","journal-title":"Nihon Shokakibyo Gakkai Zasshi."},{"issue":"101","key":"21899_CR11","first-page":"694","volume":"57","author":"A Nanashima","year":"2010","unstructured":"Nanashima, A. et al. Measurement of serum marker for bone metastasis (1-CTP) in hepatobiliary and pancreas malignancies. Hepatogastroenterology. 57(101), 694\u2013697 (2010).","journal-title":"Hepatogastroenterology."},{"issue":"4","key":"21899_CR12","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P., Gonen, M., Smith, J. J. & DeMatteo, R. P. Nomograms in oncology: More than meets the eye. Lancet Oncol. 16(4), e173-180 (2015).","journal-title":"Lancet Oncol."},{"issue":"6","key":"21899_CR13","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/MPA.0000000000001563","volume":"49","author":"D Goldstein","year":"2020","unstructured":"Goldstein, D. et al. Nomogram for estimating overall survival in patients with metastatic pancreatic cancer. Pancreas 49(6), 744\u2013750 (2020).","journal-title":"Pancreas"},{"issue":"9","key":"21899_CR14","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/cam4.2930","volume":"9","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Development and validation of a novel nomogram for pretreatment prediction of liver metastasis in pancreatic cancer. Cancer Med. 9(9), 2971\u20132980 (2020).","journal-title":"Cancer Med."},{"issue":"1","key":"21899_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/JP9.0000000000000059","volume":"4","author":"J Ding","year":"2021","unstructured":"Ding, J. et al. Prognostic Nomogram for pancreatic cancer with lung metastasis: A SEER database-based study. J. Pancreatol. 4(1), 28\u201336 (2021).","journal-title":"J. Pancreatol."},{"issue":"2","key":"21899_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.hbpd.2020.12.020","volume":"20","author":"J Hua","year":"2021","unstructured":"Hua, J. et al. Development and multicenter validation of a nomogram for preoperative prediction of lymph node positivity in pancreatic cancer (NeoPangram). Hepatobiliary Pancreat. Dis. Int. HBPD INT. 20(2), 163\u2013172 (2021).","journal-title":"Hepatobiliary Pancreat. Dis. Int. HBPD INT."},{"issue":"4","key":"21899_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00006676-199511000-00005","volume":"11","author":"T Kamisawa","year":"1995","unstructured":"Kamisawa, T., Isawa, T., Koike, M., Tsuruta, K. & Okamoto, A. Hematogenous metastases of pancreatic ductal carcinoma. Pancreas 11(4), 345\u2013349 (1995).","journal-title":"Pancreas"},{"issue":"1","key":"21899_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66(1), 7\u201330 (2016).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"21899_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12885-020-06995-y","volume":"20","author":"C Hu","year":"2020","unstructured":"Hu, C. et al. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma. BMC Cancer 20(1), 494\u2013494 (2020).","journal-title":"BMC Cancer"},{"issue":"1","key":"21899_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1186\/s12885-020-07635-1","volume":"20","author":"Z Huang","year":"2020","unstructured":"Huang, Z. et al. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: A population-based study. BMC Cancer 20(1), 1145 (2020).","journal-title":"BMC Cancer"},{"key":"21899_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijsu.2020.06.018","volume":"80","author":"B Yan","year":"2020","unstructured":"Yan, B. et al. Characteristics and risk differences of different tumor sizes on distant metastases of hepatocellular carcinoma: A retrospective cohort study in the SEER database. Int. J. Surg. (London, England). 80, 94\u2013100 (2020).","journal-title":"Int. J. Surg. (London, England)."},{"issue":"4","key":"21899_CR22","first-page":"704","volume":"15","author":"GM Petersen","year":"2006","unstructured":"Petersen, G. M. et al. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cospons. Am. Soc. Prev. Oncol. 15(4), 704\u2013710 (2006).","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cospons. Am. Soc. Prev. Oncol."},{"issue":"2","key":"21899_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jnci\/djp466","volume":"102","author":"KA Brune","year":"2010","unstructured":"Brune, K. A. et al. Importance of age of onset in pancreatic cancer kindreds. J. Natl. Cancer Inst. 102(2), 119\u2013126 (2010).","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"21899_CR24","first-page":"2829","volume":"18","author":"L Wang","year":"2009","unstructured":"Wang, L. et al. Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cospons. Am. Soc. Prev. Oncol. 18(11), 2829\u20132834 (2009).","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cospons. Am. Soc. Prev. Oncol."},{"issue":"12","key":"21899_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.3617","volume":"153","author":"S van Roessel","year":"2018","unstructured":"van Roessel, S. et al. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg. 153(12), e183617 (2018).","journal-title":"JAMA Surg."},{"issue":"14","key":"21899_CR26","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMsa0903048","volume":"361","author":"AA Ghaferi","year":"2009","unstructured":"Ghaferi, A. A., Birkmeyer, J. D. & Dimick, J. B. Variation in hospital mortality associated with inpatient surgery. N. Engl. J. Med. 361(14), 1368\u20131375 (2009).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"21899_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/SLA.0000000000002248","volume":"267","author":"C Krautz","year":"2018","unstructured":"Krautz, C., Nimptsch, U., Weber, G. F., Mansky, T. & Gr\u00fctzmann, R. Effect of hospital volume on in-hospital morbidity and mortality following pancreatic surgery in Germany. Ann. Surg. 267(3), 411\u2013417 (2018).","journal-title":"Ann. Surg."},{"issue":"1","key":"21899_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00001648-200301000-00013","volume":"14","author":"DT Silverman","year":"2003","unstructured":"Silverman, D. T. et al. Why do Black Americans have a higher risk of pancreatic cancer than White Americans?. Epidemiology 14(1), 45\u201354 (2003).","journal-title":"Epidemiology"},{"issue":"4","key":"21899_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00432-012-1156-8","volume":"138","author":"V Singal","year":"2012","unstructured":"Singal, V., Singal, A. K. & Kuo, Y. F. Racial disparities in treatment for pancreatic cancer and impact on survival: A population-based analysis. J. Cancer Res. Clin. Oncol. 138(4), 715\u2013722 (2012).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"21899_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cam4.1277","volume":"7","author":"R Nipp","year":"2018","unstructured":"Nipp, R. et al. Disparities in cancer outcomes across age, sex, and race\/ethnicity among patients with pancreatic cancer. Cancer Med. 7(2), 525\u2013535 (2018).","journal-title":"Cancer Med."},{"issue":"2","key":"21899_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.seminoncol.2003.12.031","volume":"31","author":"PC Enzinger","year":"2004","unstructured":"Enzinger, P. C. & Mayer, R. J. Gastrointestinal cancer in older patients. Semin. Oncol. 31(2), 206\u2013219 (2004).","journal-title":"Semin. Oncol."},{"issue":"6","key":"21899_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00130404-200511000-00002","volume":"11","author":"R Yancik","year":"2005","unstructured":"Yancik, R. Population aging and cancer: A cross-national concern. Cancer J. (Sudbury, Mass). 11(6), 437\u2013441 (2005).","journal-title":"Cancer J. (Sudbury, Mass)."},{"issue":"7","key":"21899_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/MPA.0b013e318258055c","volume":"41","author":"S Egawa","year":"2012","unstructured":"Egawa, S. et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 41(7), 985\u2013992 (2012).","journal-title":"Pancreas"},{"issue":"18","key":"21899_CR34","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff, D. D. et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 369(18), 1691\u20131703 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"21899_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/COC.0000000000000193","volume":"40","author":"RD Peixoto","year":"2017","unstructured":"Peixoto, R. D. et al. Eligibility of metastatic pancreatic cancer patients for first-line palliative intent nab-paclitaxel plus gemcitabine versus FOLFIRINOX. Am. J. Clin. Oncol. 40(5), 507\u2013511 (2017).","journal-title":"Am. J. Clin. Oncol."},{"issue":"8","key":"21899_CR36","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/ijms18081622","volume":"18","author":"S Heinrich","year":"2017","unstructured":"Heinrich, S. & Lang, H. Neoadjuvant therapy of pancreatic cancer: Definitions and benefits. Int. J. Mol. Sci. 18(8), 1622 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"21899_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","volume":"4","author":"AH Morrison","year":"2018","unstructured":"Morrison, A. H., Byrne, K. T. & Vonderheide, R. H. Immunotherapy and prevention of pancreatic cancer. Trends Cancer. 4(6), 418\u2013428 (2018).","journal-title":"Trends Cancer."},{"issue":"16","key":"21899_CR38","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1042\/CS20191211","volume":"134","author":"G van Duijneveldt","year":"2020","unstructured":"van Duijneveldt, G., Griffin, M. D. W. & Putoczki, T. L. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clin. Sci. (London, England: 1979) 134(16), 2091\u20132115 (2020).","journal-title":"Clin. Sci. (London, England: 1979)"},{"issue":"10","key":"21899_CR39","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1158\/1078-0432.CCR-15-1732","volume":"22","author":"MR Farren","year":"2016","unstructured":"Farren, M. R. et al. Systemic immune activity predicts overall survival in treatment-na\u00efve patients with metastatic pancreatic cancer. Clin. Cancer Res. 22(10), 2565\u20132574 (2016).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21899-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T14:14:09Z","timestamp":1666880049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21899-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21899"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21899-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"7 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18085"}}